.Merck defeats profits assumptions, rears sales overview on strong requirement for top medications like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Estimates as Keytruda Sales Increase BloombergMerck Sell: Pharma Giant Posts Powerful Results, However Overview Tumbles Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats earnings and sales requirements in the middle of Keytruda asset, yet offers mixed full-year expectation MarketWatch.